Enzolytics

ENZC · OTC

$0.0004−$0.0001 (−20.00%)TodayMarket closed · Oct 20, 3:53 PM ET

Prev close $0.0005

About ENZC

Enzolytics, Inc. is a biotechnology company, which engages in the development and commercialization of drugs for infectious disease treatments. The company is headquartered in Plano, Texas. The company went IPO on 2008-12-29. The firm is focused on commercializing its licensed proprietary proteins and monoclonal antibodies to treat debilitating infectious diseases to include the additional contracted areas of sales, marketing and distribution of medical devices, medical testing and nutraceutical products. Its subsidiaries include BioClonetics lmmunotherapy, Inc. and Biogenysis, Inc.

Employees: 0
Headquarters: Plano, Texas
Listed: Dec 29, 2008
Sector: Health Care
Industry: Biotechnology
Website: enzolytics.com

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Enzolytics suppliers and customers
Company	Relationship	Country	Correlation
SAMSUNG BIOLOGICS	Supplier	KR	—

Similar companies

Companies in the same industry as Enzolytics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.